Primary Small Cell Neuroendocrine Carcinoma of the Mediastinum: Case Report of a Rare Entity
Article Sidebar
Main Article Content
Abstract
Small neuroendocrine carcinoma of the mediastinum (SCNCM) is a rare subtype of neuroendocrine malignancy characterized by its aggressive behavior and high rates of recurrence and metastasis. The diagnosis of this carcinoma is challenging, requiring confirmation through histopathological and immunohistochemical analysis, as well as specific imaging studies. This study reports a case of primary SCNCM that resulted in the death of a 59-year-old female patient treated at the Clinical Hospital, School of Medicine, Botucatu. The diagnostic proposal of primary small cell neuroendocrine carcinoma of the mediastinum was confirmed after a detailed analysis of the organs in an autopsy examination.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Li J, Xia T, Zhang W, He P, Guan Y. Primary small cell neuroendocrine carcinoma of the mediastinum: computed tomography and histopathological correlation. J Comput Assist Tomogr. 2014;38(2):174–8.
Wang HL, Sun ZG, Xiao W, Zhu LM. Mediastinum primary small cell neuroendocrine carcinoma. Contemp Oncol (Pozn). 2016;20(1):86–90.
Bakhos CT, Wang SC, Tedesco KL, DeJesus AD, Nozad S, Depan HJ. Primary Neuroendocrine Carcinoma of the Middle Mediastinum Involving the Right Main Pulmonary Artery. Ann Thorac Surg. abril de 2016;101(4):1594–6.
Wick MR, Rosai J. Neuroendocrine neoplasms of the mediastinum. Semin Diagn Pathol. fevereiro de 1991;8(1):35–51.
Costanzo LR, Kewan T, Kerwin K, Daw H. Primary Mediastinal Small Cell Neuroendocrine Carcinoma Presenting with Superior Vena Cava Syndrome. Cureus. 10 de junho de 2019;11(6):e4873.
World Health Organization. WHO Classification of Tumours Online. Thoracic Tumors. 5th ed. Lyon, France: International Agency for Research on Cancer; 2023.
Brcic L, Heidinger M, Popper H. [Neuroendocrine neoplasms of the mediastinum]. Pathologe. setembro de 2016;37(5):434–40.
Higdon ML, Higdon JA. Treatment of oncologic emergencies. Am Fam Physician. 1o de dezembro de 2006;74(11):1873–80.
Verset L, Arvanitakis M, Loi P, Closset J, Delhaye M, Remmelink M, et al. TTF-1 positive small cell cancers: Don’t think they’re always primary pulmonary! World J Gastrointest Oncol. 15 de outubro de 2011;3(10):144–7.
Montero-Hadjadje M, Vaingankar S, Elias S, Tostivint H, Mahata SK, Anouar Y. Chromogranins A and B and secretogranin II: evolutionary and functional aspects. Acta Physiol (Oxf). fevereiro de 2008;192(2):309–24.
Bohnenberger H, Dinter H, König A, Ströbel P. Neuroendocrine tumors of the thymus and mediastinum. J Thorac Dis. no-vembro de 2017;9(Suppl 15):S1448–57.
Agoff SN, Lamps LW, Philip AT, Amin MB, Schmidt RA, True LD, et al. Thyroid transcription factor-1 is expressed in extra-pulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Mod Pathol. março de 2000;13(3):238–42.
Morana G, Cugini C, Mucelli RP. Small liver lesions in oncologic patients: characterization with CT, MRI and con-trast-enhanced US. Cancer Imaging. 4 de outubro de 2008;8 Spec No A(Spec Iss A):S132-135.
Dai W, Liu M, Zhuang X, Li Q, Wang D. Mediastinal small cell carcinoma: a unique clinical entity? Clin Transl Oncol. maio de 2016;18(5):515–20.